Several signaling pathways such as the ß-catenin or the mTOR pathway have been shown to be among the downstream signaling pathways activated by PTPRZ1, and this activation occurs in glioma cells as well as in the stimulation of oligodendrocyte progenitor cell growth [132]. Here, MTOR is linked to central nervous system cancer.